Evidence map›Paper›PMID 37880628›Full record

ArticleBMC public health2023

Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.

Paballo Mataboge, Nqaba Mthimkhulu, Alison Kutywayo, Catherine E Martin, Mbali Mazibuko, Khanyiswa Kwatsha, Nthabiseng Makalela, Elmari Briedenhann, Vusile Butler, Rutendo Bothma and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paballo MatabogeWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. pmataboge@wrhi.ac.za.
Nqaba MthimkhuluWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Alison KutywayoWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Catherine E MartinWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Mbali MazibukoWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Khanyiswa KwatshaWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Nthabiseng MakalelaWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Elmari BriedenhannWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Vusile ButlerWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Rutendo BothmaWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Saiqa MullickWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSouth African women, including female sex workers (FSWs), are disproportionately affected by HIV, experience a high unmet need for contraception and high rates of sexually transmitted infections (STIs). Products that address the interlinked risk between HIV, unplanned pregnancy, and other STIs are needed. There are several multipurpose-prevention technologies (MPTs) in development, aimed at preventing both HIV and pregnancy. This study aimed to explore educational messaging and demand creation channels to improve the potential uptake of a hypothetical MPT implant, using participatory action research. It also aimed to look at product and service provision attributes preferred by potential end users.

methodsBetween July and August 2022, 303 PrEP-eligible adolescent girls and young women (AGYW) (18-24 years), women > 24 years, and FSW's (≥ 18 years) participated in 4-hour workshops, where they were asked about their ideal messaging and demand creation channels and their preferences for different attributes of an MPT implant. Quantitative descriptive analysis was conducted to determine the frequency and ranking for each demand creation message, channel, and each product and service provision attribute, by population group. A chi-square test was used to assess MPT implant characteristics associated with age. Qualitative data were analysed using deductive and thematic analysis.

resultsA total of 104 AGYW, 157 women > 24 years, and 42 FSWs participated in the PAR workshops. Participants preferred demand creation messages that were empowering, motivational and encouraged body autonomy. The use of slang was popular. Community radio stations and newspapers, social media, and information at hospitals and clinics were participants' preferred MPT demand creation channels because they were easily accessible. Providing long-term and dual HIV and pregnancy protection, receiving implant services at the local clinic, manageable side effects, discreet and private implant, and numbing the area before insertion and removal, were the most preferred product and service provision attributes.

conclusionEarly considerations for women's product preferences are key to product development. Educational messaging around the MPT implant should be empowering and in local languages, this may motivate women to learn more about it and use it. Multiple demand creation channels should be used to engage both young and older populations, which may ensure better reach.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisSexually Transmitted DiseasesSex WorkersAdolescentContraceptionFemaleHumansPregnancySouth AfricaContraceptionDemand creationHIV preventionMultipurpose-prevention technologySouth AfricaWomen

Identifiers

PMID37880628
PMCPMC10598950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.